Archives of Toxicology

, Volume 86, Issue 9, pp 1337–1348

Cytokines in alcoholic liver disease

Review Article

Abstract

Alcoholic liver disease (ALD) is associated with a spectrum of liver injury ranging from steatosis and steatohepatitis to fibrosis and cirrhosis. While multifactorial pathogenesis plays a role in the disease progression, enhanced inflammation in the liver during ethanol exposure is a major feature of ALD. Dysregulated cytokine metabolism and activity are crucial to the initiation of alcohol-induced liver injury. The pro-inflammatory cytokine tumor necrosis factor (TNF-α) has been demonstrated to be one of the key factors in the various aspects of pathophysiology of ALD. The immunomodulatory cytokines such as interleukin 10 and interleukin 6 play roles in exerting hepatic protective effects. Adiponectin is an adipose tissue–derived hormone, which displays protective actions on ethanol-induced liver injury. Treatment for mice with adiponectin decreases TNF-α expression, steatosis and prevents alcohol-induced liver injury. Adiponectin exerts its anti-inflammatory effects via suppression of TNF-α expression and induction of anti-inflammatory cytokines such as IL-10. Adiponectin attenuates alcoholic liver injury by the complex network of multiple signaling pathways in the liver, leading to enhanced fatty acid oxidation and reduced steatosis. Interactions between pro- and anti-inflammatory cytokines such as TNFα and adiponectin and other cytokines are likely to play important roles in the development and progression of alcoholic liver disease.

Keywords

TNF-α Pro-inflammatory Adiponectin Anti-inflammatory IL-6 IL-10 Hepatoprotective Alcohol 

References

  1. Adachi Y, Moore LE, Bradford BU, Gao W, Thurman RG (1995) Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 108:218–224PubMedCrossRefGoogle Scholar
  2. Albano E (2008) Oxidative mechanisms in the pathogenesis of alcoholic liver disease. Mol Aspects Med 29:9–19PubMedCrossRefGoogle Scholar
  3. Arita Y, Kihara S, Ouchi N, Takahasshi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraquchi M, Ohmoto Y, Funahashi T, Matsuzwa Y (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79–83PubMedCrossRefGoogle Scholar
  4. Awazasa M, Ueki K, Inabe K, Yamauchi T, Kaneko K, Okazaki Y, Bardeesy N, Ohnishi S, Nagai R, Kadowaki T (2009) Adiponectin suppresses hepatic SREBP1c expression in an AdipoR1/LKB1/AMPK dependent pathway. Biochem Biophys Res Commun 382:51–56CrossRefGoogle Scholar
  5. Berg DJ, Kuhn R, Rajewsky K, Muller W, Menon S, Davidson N, Grunig G, Rennick D (1995) Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest 96:2339–2347PubMedCrossRefGoogle Scholar
  6. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE (2001) The adipocyte-secreted protein Acrp 30 enhances hepatic insulin action. Nat Med 7:947–953PubMedCrossRefGoogle Scholar
  7. Bird GLA, Sheron N, Goka AKJ, Alexander GL, Williams RS (1990) Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 112:917–920PubMedGoogle Scholar
  8. Bouskila M, Pajvani UB, Scherer PE (2005) Adiponectin: a relevant player in PPAR-gamma-agonist-mediated improvements in hepatic insulin sensitivity? Int J Obes 29:S17–S23CrossRefGoogle Scholar
  9. Canbay A, Feldstein AE, Higuchi H, Werneburg N, Grambihler A, Bronk SF, Gores GJ (2003) Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. Hepatology 38:1188–1198PubMedCrossRefGoogle Scholar
  10. Chaisson ML, Brooling JT, Ladiges W, Tsai S, Fausto N (2002) Hepatocyte-specific inhibition of NF-κB leads to apoptosis after TNF treatment, but not after partial hepatectomy. J Clin Invest 110:193–202PubMedGoogle Scholar
  11. Choudhry MA, Fazal N, Goto M, Gamelli RL, Sayeed MM (2002) Gut-associated lymphoid T cell suppression enhances bacterial translocation in alcohol and burn injury. Am J Physiol Gastrointest Liver Physiol 282:G937–G947PubMedGoogle Scholar
  12. Croker BA, Krebs DL, Zhang JG, Wormald S, Wilson TA, Stanley EG, Robb L, Greengalgh CJ, Forster I, Clausen BE, Nicola NA, Metcalf D, Hilton DJ, Roberts AW, Alexander WS (2003) SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol 4:540–545PubMedCrossRefGoogle Scholar
  13. Davis RJ (2000) Signal transduction by the JNK group of MAP kinases. Cell 103:239–252PubMedCrossRefGoogle Scholar
  14. Deaciuc IV, D’Souza NB, Spitzer JJ (1995) Tumor necrosis factor-α cell-surface receptors of liver parenchymal and nonparenchymal cells during acute and chronic alcohol administration to rats. Alcohol Clin Exp Res 19:332–338PubMedCrossRefGoogle Scholar
  15. El-Assal O, Hong F, Kim WH, Radaeva S, Gao B (2004) IL-6 deficient mice are susceptible to ethanol-induced hepatic steatosis: IL-6 protects against ethanol-induced oxidative stress and mitochondrial permeability transition in the liver. Cell Mol Immunol 1(3):205–211PubMedGoogle Scholar
  16. Endo M, Masaki T, Seike M, Yoshimatsu H (2007) TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c. Exp Biol Med 232:614–621Google Scholar
  17. Esfandiari F, You M, Villanueva JA, Wong DH, French SW, Halsted CH (2007) S-adenosylmethionine attenuates hepatic lipid synthesis in micropigs fed ethanol with a folate- deficient diet. Alcohol Clin Exp Res 31:1231–1239PubMedCrossRefGoogle Scholar
  18. Feldstein AE, Werneburg NW, Canbay A, Guicciardi ME, Bronk SF, Rydzewski R, Brugart LJ, Gores GJ (2004) Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology 40:185–194PubMedCrossRefGoogle Scholar
  19. Felver ME, Mezey E, McGuire M, Mitchell MC, Herlong HF, Veech VA, Veech RL (1990) Plasma tumor necrosis factor a predicts decreased long term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res 14:255–259PubMedCrossRefGoogle Scholar
  20. Fernandez-Checa JC, Kaplowitz N, Garcia-Ruiz C, Colell A, Miranda M, Mari M, Ardite E, Morales A (1997) GSH transport in mitochondria: defense against TNF-induced oxidative stress and alcohol-induced defect. Am J Physiol 273:G7–G17PubMedGoogle Scholar
  21. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O’Garra A (1991) IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146:3444–3451PubMedGoogle Scholar
  22. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, Bihain BE, Lodish HF (2001) Proteolytic cleavage product of 30-kDa adipocyte complement- related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Acad Sci USA 98:2005–2010Google Scholar
  23. Gao B (2005) Cytokines, STATs and liver disease. Cell Mol Immunol 2:92–100PubMedGoogle Scholar
  24. Garcia-Villafranca J, Guillen A, Castro J (2008) Ethanol consumption impairs regulation of fatty acid metabolism by decreasing the activity of AMP-activated protein kinase in rat liver. Biochimie 90:460–466PubMedCrossRefGoogle Scholar
  25. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Nuwen G, Schaper F (2003) Principles of interleukin (IL)-6-type cytokine signaling and its regulation. Biochem J 374:1–20PubMedCrossRefGoogle Scholar
  26. Hibi M, Nakajima K, Hirano T (1996) IL-6 cytokine family and signal transduction: a model of the cytokine system. J Mol Med 74:1–12PubMedCrossRefGoogle Scholar
  27. Higuchi M, Aggarwal BB, Yeh ET (1997) Activation of CPP32-like protease in tumor necrosis factor-induced apoptosis is dependent on mitochondrial function. J Clin Invest 99:1751–1758PubMedCrossRefGoogle Scholar
  28. Hill DB, Marsano L, Cohen D, Allen J, Shedlofsky S, McClain CJ (1992) Increased plasma interleukin-6 concentrations in alcoholic hepatitis. J Lab Clin Med 119(5):547–552PubMedGoogle Scholar
  29. Hill DB, Schmidt J, Sheldlofsky S, Cohen D, McClain CJ (1995) In vitro tumor necrosis factor cytotoxicity in HepG2 liver cells. Hepatology 21:1114–1119PubMedGoogle Scholar
  30. Hill DB, D’Souza NB, Lee EY, Burikhanor R, Deaciuc IV, de Villiers WJ (2002) A role for interleukin-10 in alcohol-induced liver sensitization to bacterial lipopolysaccharide. Alcohol Clin Exp Res 26(1):74–82PubMedCrossRefGoogle Scholar
  31. Hines IN, Wheeler MD (2004) Recent advances in alcoholic liver disease III. Role of the innate immune response in alcoholic hepatitis. Am J Physiol Gastrointest Liver Physiol 287:G310–G314PubMedCrossRefGoogle Scholar
  32. Honchel R, Ray MB, Marsano L (1992) Tumor necrosis factor in alcohol enhanced endotoxin liver injury. Alcohol Clin Exp Res 16:665–669PubMedCrossRefGoogle Scholar
  33. Hong F, Kim WH, Tian Z, Jaruga B, Ishac E, Shen X, Gao B (2002) Elevated interleukin- 6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver: involvement of induction of Bcl-2 and Bcl-x(L) proteins. Oncogene 21(1):32–43PubMedCrossRefGoogle Scholar
  34. Hong F, Radaeva S, Pan HN, Tian Z, Veech R, Gao B (2004) Interlerlin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease. Hepatology 40(4):933–941PubMedGoogle Scholar
  35. Horiguchi N, Wang L, Mukhopadhyay P, Park O, Jeong WI, Lafdil F, Osei-Hyiaman D, Moh A, Fu XY, Pacher P, Kunos G, Gao B (2008) Cell type-dependent pro-and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury. Gastroenterology 134(4):1148–1158PubMedCrossRefGoogle Scholar
  36. Iimuro Y, Gallucci RM, Luster MI, Kono H, Thurman RG (1997) Antibodies to tumor necrosis factor-α attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 26:1530–1537PubMedCrossRefGoogle Scholar
  37. Inoue H, Ogawa W, Ozaki M, Haga S, Matsumoto M, Furukawa K, Hashimoto N, Kido Y, Mori T, Sakaue H, Teshiquware K, Jin S, Iquch H, Hiramatsu R, LeRoith D, Takeda K, Akira S, Kasuga M (2004) Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo. Nat Med 10:168–174PubMedCrossRefGoogle Scholar
  38. Jay MA, Ren J (2007) Peroxisome proliferator-activated receptor (PPAR) in metabolic syndrome and type 2 diabetes mellitus. Curr Diabetes Rev 3:33–39PubMedCrossRefGoogle Scholar
  39. Ji C, Kaplowitz N (2003) Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice. Gastroenterology 124:1488–1499PubMedCrossRefGoogle Scholar
  40. Ji C, Chan C, Kaplowitz N (2006) Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model. J Hepatol 45:717–724PubMedCrossRefGoogle Scholar
  41. Joshi-Barve S, Barve SS, Butt W, Klein J, McClain CJ (2003) Inhibition of proteasome function leads to NF-κB-independent IL-8 expression in human hepatocytes. Hepatology 38:1178–1187PubMedCrossRefGoogle Scholar
  42. Joshi-Barve S, Barve SS, Amancherla K, Gobejishvili L, Hill D, Cave M, Hote P, McClain CJ (2007) Palmitic acid induces production of proinflammatory cytokine Interleukin-8 from hepatocytes. Hepatology 46:823–830PubMedCrossRefGoogle Scholar
  43. Kadowaki T, Yamuchi T, Kubota N, Hara K, Ueki K, Tobe K (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116:1784–1792PubMedCrossRefGoogle Scholar
  44. Kamimura S, Tsukamoto H (1995) Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease. Hepatology 21:1304–1309Google Scholar
  45. Keshavarzian A, Fields JZ, Vaeth J, Holmes EW (1994) The differing effects of acute and chronic alcohol on gastric and intestinal permeability. Am J Gastroenterol 89:2205–2211PubMedGoogle Scholar
  46. Knolle P, Schlaak J, Uhrig A, Kempf P, Meyer zum Buschenfelde KH, Gerken G (1995) Human Kupffer cells secrete IL-10 in response to lipopolysacharide (LPS) challenge. J Hepatol 22:226–229PubMedCrossRefGoogle Scholar
  47. Lawler JF Jr, Yin M, Diehl AM, Roberts E, Chatterjee S (1998) Tumor necrosis factor-alpha stimulates the maturation of sterol regulatory element binding protein-1 in human hepatocytes through the action of neutral sphingomyelinase. J Biol Chem 273:5053–5059PubMedCrossRefGoogle Scholar
  48. Li W, Liang X, Kellendonk C, Poli V, Taub R (2002) STAT3 contributes to the mitogenic response of heptocytes during liver regeneration. J Biol Chem 277:28411–28417PubMedCrossRefGoogle Scholar
  49. Louis H, Le Moine O, Goldman M, Deviere J (2003) Modulation of liver injury by interleukin-10. Acta Gastroenterol Belg 66(1):7–14PubMedGoogle Scholar
  50. Lu Y, Cederbaum AI (2008) CYE2E1 and oxidative liver injury by alcohol. Free Radic Biol Med 44(5):723–738PubMedCrossRefGoogle Scholar
  51. Lu Y, Cederbaum AL (2010) CYP2E1 potentiation of LPS and TNF-α-induced hepatotoxicity by mechanisms involving enhanced oxidative and nitrosative stress, activation of MAP kinases and mitochondrial dysfunction. Genes Nutr 5:149–167PubMedCrossRefGoogle Scholar
  52. Lu YC, Yeh WC, Ohashi PS (2008) LPS/TLR4 signal transduction pathway. Cytokine 42:145–151PubMedCrossRefGoogle Scholar
  53. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N, Kuriyama H, Hotta K, Nakamura T, Shimomura I, Matsuzawa Y (2001) PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes. 50(9):2094–2099PubMedCrossRefGoogle Scholar
  54. Mandrekar P, Szabo G (2009) Signalling pathway in alcohol-induced liver inflammation. J Hepatol 50:1258–1266PubMedCrossRefGoogle Scholar
  55. Masaki T, Chiba S, Tatsukawa H, Yasuda T, Noguchi H, Seike M, Yoshimatsu H (2004) Adiponecin protects LPS-induced liver injury through modulation of TNF-α in KK-Ay obese mice. Hepatology 40:177–184PubMedCrossRefGoogle Scholar
  56. Matsubara M, Maruoka S, Katayose S (2002) Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol 147:173–180PubMedCrossRefGoogle Scholar
  57. Matsumoto H, Tamura S, Kamada Y, Kiso S, Fukushima J, Wada A, Maeda N, Kihara S, Funahashi T, Matsuzawa Y, Shimomura I, Hayashi H (2006) Adiponectin deficiency exacerbates lipopolysaccharide/D-galactosamine-induced liver injury in mice. World J Gastroenterol 12:3352–3358PubMedGoogle Scholar
  58. McClain CJ, Cohen DA (1989) Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 9:349–351PubMedCrossRefGoogle Scholar
  59. McClain CJ, Barve S, Deaciuc I, Kugelmas M, Hill D (1999) Cytokines in alcoholic liver desease. Semin Liver Dis 19:205–219PubMedCrossRefGoogle Scholar
  60. McClain CJ, Hill DB, Song Z, Chawla R, Watson WH, Chen T, Barve S (2002) S-Adenosyl-methionine, cytokines, and alcoholic liver disease. Acohol. 27(3):185–192Google Scholar
  61. McClain CJ, Song Z, Barve SS, Hill DB, Deaciuc I (2004) Recent advances in alcoholic liver diseses IV. Dysregulated cytokine metabolism in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 287:G497–G502PubMedCrossRefGoogle Scholar
  62. Miller AM, Wang H, Park O, Horiguchi N, Lafdil F, Mukhopadhyay P, Moh A, Fu XY, Kunos G, Pacher P, Gao B (2010) Anti-inflammatory and anti-apoptotic roles of endothelial cell STAT3 in alcoholic liver injury. Alcohol Clin Exp Res 34(4):719–725PubMedCrossRefGoogle Scholar
  63. Miller AM, Wang H, Bertola A, Park O, Horiguchi M, Ki SH, Yin S, Lafdil F, Gao B (2011) Molecular mechanisms of alcoholic liver diseases: innate immunity and cytokines. Alcohol Clin Exp Res 35(5):787–793PubMedCrossRefGoogle Scholar
  64. Miura K, Kodama Y, Inokuchi S, Schnabl B, Aoynama T, Ohnish H, Olefsky JM, Brenner DA, Seki E (2010) Toll-like receptor 9 promotes steatohepatitis by induction of Interleukin-1 beta in mice. Gastroenterology 139(323–334):e7PubMedGoogle Scholar
  65. Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683–765PubMedCrossRefGoogle Scholar
  66. Murray PJ (2007) The JAK-STAT signaling pathway: input and output integration. J Immunol 178:2623–2629PubMedGoogle Scholar
  67. Nanji AA, Zhao S, Sadrzadeh SM, Waxman DJ (1994a) Use of reverse transcription-polymerase chain reaction to evaluate in vivo cytokine gene expression in rats fed ethanol for long periods. Hepatology 19:1483–1487PubMedGoogle Scholar
  68. Nanji AA, Khettry U, Sadrzadeh SM (1994b) Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver disease. Proc Soc Exp Biol Med 205:243–247PubMedGoogle Scholar
  69. Neuman MG, Shear NH, Bellentani S, Tiribelli C (1998) Role of cytokines in ethanol-induced cytotoxicity in vitro in HepG2 cell. Gastroenterology 115:157–166PubMedCrossRefGoogle Scholar
  70. Neumeier M, Weigert J, Schaffler A, Weiss T, Kirchner S, Laberer S, Scholmerich J, Buechler C (2005) Regulation of adiponectin receptor 1 in human hepatocytes by agonists of nuclear receptors. Biochem Biophys Res Commun 334:924–929PubMedCrossRefGoogle Scholar
  71. Neumeier M, Weigert J, Schaffler A, Wehrwein G, Muller-Ladner U, Scholmerich J, Wrede C, Buechler C (2006) Different effects of adiponectin isoforms in human Monocytic cells. J Leukoc Biol 79:803–808PubMedCrossRefGoogle Scholar
  72. Neushwander-Tetri BA (2010) Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology 52:774–788CrossRefGoogle Scholar
  73. O’Shea RS, Dasarathy S, McCullough AJ (2010) Alcoholic liver disease. Hepatology 51(1):307–328PubMedCrossRefGoogle Scholar
  74. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Funahashi T, Matwuzawa Y (2000) Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102:1296–1301PubMedCrossRefGoogle Scholar
  75. Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, Schulthess T, Engel J, Brownlee M, Scherer PE (2003) Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity. J Biol Chem 278:9073–9085PubMedCrossRefGoogle Scholar
  76. Park PH, McMullen MR, Huang H, Thakur V, Nagy LE (2007) Short-term treatment of RAW264.7 macrophages with adiponectin increases tumor necrosis factor-alpha (TNF-α) expression via ERK1/2 activation and Egr-1 expression: role of TNF-α in adiponectin-stimulated interleukin-10 production. J Biol Chem 282:21695–21703PubMedCrossRefGoogle Scholar
  77. Parlesak A, Schafer C, Schutz T, Bode JC, Bode C (2000) Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J Hepatol 32:742–747PubMedCrossRefGoogle Scholar
  78. Purohit V, Gao B, Song B-J (2009) Molecular mechanisms of alcoholic fatty liver. Alcohol Clin Exp Res 33(2):191–205PubMedCrossRefGoogle Scholar
  79. Qureshi K, Abrams GA (2007) Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol 13:3540–3553PubMedGoogle Scholar
  80. Rai RM, Loffreda S, Karp CL, Yang SQ, Lin HZ, Diehl AM (1997) Kupffer cell depletion abolishes induction of interleukin-10 and permits sustained overexpression of tumor necrosis factor alpha messenger RNA in the regenerating rat liver. Hepatology 25:889–895PubMedCrossRefGoogle Scholar
  81. Rao RK, Seth A, Sheth P (2004) Recent advances in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 280:G881–G884CrossRefGoogle Scholar
  82. Rogers CQ, Ajmo J, You M (2008) Adiponectin and alcoholic fatty liver disease. IUBMB Life 60(12):790–797PubMedCrossRefGoogle Scholar
  83. Santucci L, Fiorucci S, Chiorean M, Brunori PM, Di Matteo FM, Sidoni A, Migliorati G, Morelli A (1996) Interleukin 10 reduces lethality and hepatic injury induced by lipopolysaccharide in galactosamine-sensitized mice. Gastroenterology 111:736–744PubMedCrossRefGoogle Scholar
  84. Schottelius AJ, Mayo MW, Sartor RB, Baldwin AS Jr (1999) Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kapparB DNA binding. J Biol Chem 274:31868–31874PubMedCrossRefGoogle Scholar
  85. Schulze-Osthoff K, Bakker AC, Vanhaesebroeck B, Beyaert R, Jacob WA, Fiers W (1992) Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions: evidence for the involvement of mitochondrial radical generation. J Biol Chem 267:5317–5323PubMedGoogle Scholar
  86. Schwabe RF, Brenner DA (2006) Mechanisms of liver injury. I. TNF-α-induced liver injury: role of IKK, INK, and ROS pathways. Am J Physiol Gastrointest Liver Physiol 290:G583–G589PubMedCrossRefGoogle Scholar
  87. Sheron N, Bird G, Koskinas J, Portmann B, Ceska M, Lindley I, Williams R (1993) Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. Hepatology 18:41–46PubMedGoogle Scholar
  88. Song Z, Zhou Z, Deaciuc I, Chen T, McClain CJ (2008) Inhibition of adiponection production by homecysteine: a potential mechanism for alcoholic liver disease. Hepatology 47:867–879PubMedCrossRefGoogle Scholar
  89. Sun Z, Klein AS, Radaeva S, Hong F, El-Assal O, Pan HN, Jaruga B, Batkar S, Hoshino S, Tian Z, Kunos G, Diehl AM, Gao G (2003) In vitro interleukin- 6 treatment prevents mortality associated with fatty liver transplants in rats. Gastroenterology 125(1):202–215PubMedCrossRefGoogle Scholar
  90. Szabo G, Dolganiuc A, Mandrekar P (2006) Pattern recognition receptors: a contemporary view on liver disease. Hepatology 44:287–298PubMedCrossRefGoogle Scholar
  91. Szabo G, Mandrekar P, Dolganiuc A (2007) Innate immune response and hepatic inflammation. Semin Liver Dis 27:339–350PubMedCrossRefGoogle Scholar
  92. Thakur V, Pritchard MT, McMuller MR, Nagy LE (2006) Adiponectin normalizes LPS-stimulated TNF-α production by rat Kupffer cells after chronic ethanol feeding. Am J Physiol Gastrointest Liver Physiol 290:G998–G1007PubMedCrossRefGoogle Scholar
  93. Thurman RG (1998) II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. Am J Physiol 275:G605–G611PubMedGoogle Scholar
  94. Tilg H, Diehl AM (2000) Cytokines in alcoholic and nonalcoholic steatoheptohepatitis. N Eng J Med 343:1467–1476CrossRefGoogle Scholar
  95. Tomita K, Tamiya G, Ando S, Kitamura N, Koizumi H, Kato S, Horie Y, Kaneko T, Azuma T, Nagat H, Ishii H, Hibi T (2005) AICAR, an AMPK activator, has protective effects on alcohol induced fatty liver in rats. Alcohol Clin Exp Res 29:240S–245SPubMedCrossRefGoogle Scholar
  96. Tournier C, Dong C, Tourner TK, Jones SN, Flavell RA, Davis RJ (2001) MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines. Genes Dev 15:1419–1426PubMedCrossRefGoogle Scholar
  97. Tsatsanis C, Zacharioudaki V, Androulidaki A, Dermitzaki E, Charalampopoulos I, Minas V, Gravanis A, Margioris A (2005) Adiponectin induces TNF-α and IL-6 in macrophages and promotes tolerance to itself and other pro-inflammatory stimuli. Biochem Biophy Res Commun 335:1254–1263CrossRefGoogle Scholar
  98. Uesugi T, Froh M, Arteel GE, Bradford BU, Wheeler MD, Gabele E et al (2002) Role of lipopolysaccharide-binding protein in early alcohol-induced liver injury in mice. J Immunol 168:2963–2969PubMedGoogle Scholar
  99. Waal Malefyt R, Abrams J, Bennett B, Figdor CG, Vries JE (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209–1220Google Scholar
  100. Wajant H, Pfizenmaier K, Scheurich P (2003) Tumor necrosis factor signaling. Cell Death Differ 10:45–65PubMedCrossRefGoogle Scholar
  101. Wake H, Yamuchi T, Kamon J, Ito Y, Uchida S, Kita S, Hara K, Hada Y, Vasseur F, Froguel P, Kimura S, Nagai R (2003) Impaired multimerization of human adiponectin mutants associates with diabetes: molecular structure and multimer formation of adiponectin. J Biol Chem 278:40352–40363CrossRefGoogle Scholar
  102. Weber-Nordt RM, Riley JK, Greenlund AC, Moore KW, Darnell JE, Schreiber RD (1996) Stat3 recruitment by two distint ligand-induced, tyrosine-phosphorylated docking sites in the interleukin-10 receptor intracellular domain. J Biol Chem 271:27954–27961PubMedCrossRefGoogle Scholar
  103. Wheeler MD (2003) Endotoxin and Kupffer cell activation in alcoholic liver disease. Alcohol Res Health 27:300–306PubMedGoogle Scholar
  104. Williams LM, Ricchetti G, Sarma U, Smallie T, Foxwell BM (2004) Interleukin-10 suppression of myeloid cell activation—a continuing puzzle. Immunology 113:281–292PubMedCrossRefGoogle Scholar
  105. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431–1433PubMedCrossRefGoogle Scholar
  106. Wulster-Radcliffe MC, Ajuwon KM, Wang J, Chirstian JA, Spurlock ME (2004) Adiponectin differentially regulates cytokines in porcine macrophages. Biochem Biophys Res Commun 316:924–929PubMedCrossRefGoogle Scholar
  107. Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ (2003) The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver disease in mice. J Clin Invest 112:91–100PubMedGoogle Scholar
  108. Yamaguchi N, Guillermo J, Argueta M, Masuhiro Y, Kagishita M, Nonaka K, Saito T, Hanazawa S, Yamashita Y (2005) Adiponectin inhibits toll-like receptor family-signaling. FEBS Lett 579:6821–6826PubMedCrossRefGoogle Scholar
  109. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yodo M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T (2001) The fat- derived hormone adiponectin reverses insulin resistence associated with both lipoatrophy and obesity. Nat Med 7:941–946PubMedCrossRefGoogle Scholar
  110. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8(11):1288–1295PubMedCrossRefGoogle Scholar
  111. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yakomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T (2003) Cloining of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762–769PubMedCrossRefGoogle Scholar
  112. Yasukawa H, Ohishi M, Mori H, Murakami M, Chinen T, Aki D, Hanada T, Takeda K, Akira S, Hoshijima M et al (2003) IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat Immunol 4:551–556PubMedCrossRefGoogle Scholar
  113. Yin M, Wheeler MD, Kono H, Bradford BU, Gallucci RM, Luster MI, Thurman RG (1999) Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology 117:942–945PubMedCrossRefGoogle Scholar
  114. Yin HQ, Kim M, Kim JH, Kong G, Kang KS, Kim HI, Yoon BI, Lee MO, Lee BH (2007) Differential gene expression and lipid metabolism in fatty liver induced by acute ethanol treatment in mice. Toxicol Appl Phamacol 223(3):225–233CrossRefGoogle Scholar
  115. Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyam A, Oushi N, Kihara S, Funahashi T, Tenner AJ, Tomiyama Y, Matsuzawa Y (2000) Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96:1723–1732PubMedGoogle Scholar
  116. You M, Fischer M, Deeg MA, Crabb DW (2002) Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J Biol Chem 277:29342–29347PubMedCrossRefGoogle Scholar
  117. You M, Matsumoto M, Pacold CM, Cho WK, Crabb DW (2004) The role of AMP-activated protein kinase in the action of ethanol in the liver. Gastroenterology 127:1798–1808PubMedCrossRefGoogle Scholar
  118. You M, Considine RV, Leone TC, Kelly DP, Crabb DW (2005) Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice. Hepatology 42:568–577PubMedCrossRefGoogle Scholar
  119. You M, Liang X, Ajmo JM, Ness GC (2008) Involvement of mammalian sirtuin I in the action of ethanol in the liver. Am J Physiol Gastrointest Liver Physiol 370:44–48Google Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  1. 1.Department of Pharmacology and Systems TherapeuticsMount Sinai School of MedicineNew YorkUSA

Personalised recommendations